Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis. [electronic resource]
Producer: 20010809Description: 786-94 p. digitalISSN:- 0315-162X
- Adult
- Aged
- Alprostadil -- analogs & derivatives
- Biomarkers
- Cyclodextrins -- therapeutic use
- Endothelium, Vascular -- drug effects
- Female
- Humans
- Immune System -- drug effects
- Injections, Intravenous
- Middle Aged
- Raynaud Disease -- blood
- Reference Values
- Scleroderma, Localized -- blood
- Scleroderma, Systemic -- complications
- Treatment Outcome
- alpha-Cyclodextrins
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.